These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 32398491

  • 1. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B.
    Eur J Gastroenterol Hepatol; 2021 Apr 01; 33(4):541-546. PubMed ID: 32398491
    [Abstract] [Full Text] [Related]

  • 2. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
    Pitton MB, Zimmermann T, Mildenberger P, Weinmann A, Kloeckner R, Düber C, Mittler J, Hoppe-Lotichius M, Otto G.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
    [Abstract] [Full Text] [Related]

  • 3. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M, Hanouneh M, S Ascha M, Zein NN, Sands M, Lopez R, Hanouneh IA.
    Dig Dis Sci; 2017 Feb 01; 62(2):534-542. PubMed ID: 27154510
    [Abstract] [Full Text] [Related]

  • 4. FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    Yang C, Chen Q, Zhou C, Liu J, Huang S, Wang Y, Wang C, Ju S, Chen Y, Li T, Bai Y, Yao W, Xiong B.
    AJR Am J Roentgenol; 2022 Aug 01; 219(2):255-267. PubMed ID: 35138134
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt.
    Zhang W, Aryan M, Chen Z, Khan W, Thompson B, Kwenda E, Geller B, Morelli G.
    Eur J Gastroenterol Hepatol; 2022 Apr 01; 34(4):435-442. PubMed ID: 34750323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
    Delgado MG, Mertineit N, Bosch J, Baumgartner I, Berzigotti A.
    Dig Liver Dis; 2024 Sep 01; 56(9):1544-1550. PubMed ID: 38555198
    [Abstract] [Full Text] [Related]

  • 8. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Rajesh S, Philips CA, Betgeri SS, George T, Ahamed R, Mohanan M, Augustine P.
    Indian J Gastroenterol; 2021 Aug 01; 40(4):361-372. PubMed ID: 34324168
    [Abstract] [Full Text] [Related]

  • 9. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
    Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M, Salvage TIPS Group.
    Hepatology; 2021 Oct 01; 74(4):2085-2101. PubMed ID: 34018627
    [Abstract] [Full Text] [Related]

  • 10. MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.
    Song J, Wang X, Yan Y, Xiang T, Luo X.
    Dig Dis Sci; 2023 Jul 01; 68(7):3185-3192. PubMed ID: 36715817
    [Abstract] [Full Text] [Related]

  • 11. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M.
    J Hepatol; 2021 Jun 01; 74(6):1362-1372. PubMed ID: 33508376
    [Abstract] [Full Text] [Related]

  • 12. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
    Hermie L, Dhondt E, Vanlangenhove P, Hoste E, Geerts A, Defreyne L.
    Eur J Gastroenterol Hepatol; 2018 Dec 01; 30(12):1441-1446. PubMed ID: 30048333
    [Abstract] [Full Text] [Related]

  • 13. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A, Miraglia R, Maruzzelli L, D'Amico M, Tuzzolino F.
    Radiology; 2016 Aug 01; 280(2):622-9. PubMed ID: 26982564
    [Abstract] [Full Text] [Related]

  • 14. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F, Berzigotti A, Lisotti A, Azzaroli F, Mosconi C, Giampalma E, Renzulli M, Cappelli A, Buonfiglioli F, Calvanese C, Zoli M, Golfieri R, Mazzella G.
    Scand J Gastroenterol; 2012 Dec 01; 47(12):1494-500. PubMed ID: 22958120
    [Abstract] [Full Text] [Related]

  • 15. Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis.
    Nardelli S, Riggio O, Marra F, Gioia S, Saltini D, Bellafante D, Adotti V, Guasconi T, Ridola L, Rosi M, Caporali C, Fanelli F, Roccarina D, Bianchini M, Indulti F, Spagnoli A, Merli M, Vizzutti F, Schepis F.
    J Hepatol; 2024 Apr 01; 80(4):596-602. PubMed ID: 38097113
    [Abstract] [Full Text] [Related]

  • 16. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.
    Ahmed R, Santhanam P, Rayyan Y.
    Eur J Gastroenterol Hepatol; 2015 Oct 01; 27(10):1226-7. PubMed ID: 26111072
    [Abstract] [Full Text] [Related]

  • 17. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
    Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, McMahan CA.
    Radiology; 2004 Apr 01; 231(1):231-6. PubMed ID: 14990811
    [Abstract] [Full Text] [Related]

  • 18. Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.
    Bai YW, Liu JC, Yang CT, Wang YL, Wang CY, Ju SG, Zhou C, Huang SJ, Li TQ, Chen Y, Yao W, Xiong B.
    Eur J Gastroenterol Hepatol; 2022 Sep 01; 34(9):948-955. PubMed ID: 35594511
    [Abstract] [Full Text] [Related]

  • 19. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Young S, Rostambeigi N, Golzarian J, Lim N.
    AJR Am J Roentgenol; 2020 Jul 01; 215(1):215-222. PubMed ID: 32432911
    [Abstract] [Full Text] [Related]

  • 20. Performance of artificial intelligence for prognostic prediction with the albumin-bilirubin and platelet-albumin-bilirubin for cirrhotic patients with acute variceal bleeding undergoing early transjugular intrahepatic portosystemic shunt.
    Zhong BY, Tang HH, Wang WS, Shen J, Zhang S, Li WC, Yin Y, Yang J, Liu F, Ni CF, Zhao JB, Zhu XL.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e153-e160. PubMed ID: 33177378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.